{
    "Trade/Device Name(s)": [
        "ELITech Clinical Systems AMYLASE SL",
        "ELITech Clinical Systems ELICAL 2",
        "ELITech Clinical Systems ELITROL I",
        "ELITech Clinical Systems ELITROL II"
    ],
    "Submitter Information": "ELITech Clinical Systems SEPPIM S.A.S",
    "510(k) Number": "K122858",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063744",
        "K033501",
        "K041227"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFJ",
        "JIX",
        "JJY"
    ],
    "Summary Letter Date": "September 14, 2012",
    "Summary Letter Received Date": "September 18, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1070",
        "21CFR862.1150"
    ],
    "Regulation Name(s)": [
        "Amylase test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Amylase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ELITech Clinical Systems Selectra analyzers",
        "Selectra ProM analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic method"
    ],
    "Methodologies": [
        "Enzyme activity measurement"
    ],
    "Submission Type(s)": [
        "Kit",
        "Calibrator",
        "Control Sera"
    ],
    "Document Summary": "FDA 510(k) summary for ELITech Clinical Systems AMYLASE SL assay, calibrator, and control for quantitative determination of amylase in human serum and plasma using enzymatic methodology",
    "Indications for Use Summary": "Intended for quantitative in vitro determination of amylase in human serum and plasma on ELITech Clinical Systems Selectra analyzers, primarily for diagnosis and treatment of pancreatitis; includes associated calibrator and control products for calibration and quality control.",
    "fda_folder": "Clinical Chemistry"
}